Alex Gorsky
Former Chairman & CEO, Johnson & Johnson
Alex Gorsky is the former Chairman and Chief Executive Officer of Johnson & Johnson.
He began his Johnson & Johnson career with Janssen Pharmaceutica in 1988, advancing through positions of increasing responsibility in sales, marketing, and management until, in 2012, he became the seventh leader to serve in the dual role of Chairman and CEO. He became Executive Chairman at the end of 2021, which he held until his retirement in January 2023.
Under Alex’s leadership, Johnson & Johnson became an industry stalwart. As part of the company’s commitment to serving more than a billion people each day, Alex oversaw significant breakthroughs in public health, including the deployment of an Ebola vaccine and the development of the Janssen single-shot COVID-19 vaccine in just 13 months. He promoted a more diverse and inclusive culture at Johnson & Johnson, serving as the driving force behind many of the company’s diversity, equity, and inclusion initiatives, including a $100 million pledge to fight health inequities faced by communities of color in the United States.
Through his work as a member of the Business Roundtable and the Business Council Executive Committees, Alex’s influence has shaped both the healthcare landscape and the greater business community. He currently sits on the Board of Directors of Apple, IBM, JPMorgan Chase, and the Travis Manion Foundation, and serves on the Board of Advisors, Wharton School at the University of Pennsylvania.
Alex completed his undergraduate education at the U.S. Military Academy at West Point, and earned his MBA from Wharton in 1996.